ymphoscintigraphy of the pretreated neck in head and neck squamous cell carcinoma

• Conditions: head and neck cancer; head and neck squaumous cell carcinoma; 10038666

• Registration Number: NL-OMON30277
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

recurrent or scond primary head and neck cancer
suitable for peritumoral injection
previous treatment of lymph nodes
clinically N0 neck

Exclusion Criteria

age <18 or > 80years

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary endpoint is the lymph node drainage of recurrent or second primary<br /><br>HNSCC in the previously treated neck. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary endpoints are alteration of lymphatic drainage after previous<br /><br>treatment of the neck and influence of lymph node mapping (and sentinel node<br /><br>biopsy or cytology) on treatment planning. </p><br>